Skip to main content

Want a detailed portfolio tracker?

Puma Biotechnology (PBYI) P/E (2012 - 2026)

Puma Biotechnology (PBYI) P/E from Apr 24, 2012 to Jul 21, 2026. The TTM Puma Biotechnology (PBYI) P/E is 17.66. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Puma Biotechnology (PBYI)

YearP/EChange
202617.66+83.85%
20259.61+93.36%
20244.97-91.24%
202356.73+199.75%
202218.93-541.24%
2021-4.29-36.84%
2020-6.79+51.11%
2019-4.49-34.02%
2018-6.81-44.13%
2017-12.19+223.98%
2016-3.76-64.45%
2015-10.58-73.77%
2014-40.35-25.96%
2013-54.49+882.59%
2012-5.55N/A

Comparison Puma Biotechnology (PBYI) P/E with competitors

Puma Biotechnology (PBYI) P/E is 17.66.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.00-99.98%
ENLVEnlivex Ltd0.07-99.58%
FGENFibroGen Inc0.24-98.64%
CHRSCoherus Biosciences Inc0.85-95.20%
FBIOFortress Biotech Inc0.95-94.63%
ORMPOramed Pharmaceuticals Inc1.50-91.49%
AGENAgenus Inc3.01-82.96%
INVAInnoviva Inc3.15-82.14%
VXRTVaxart Inc3.55-79.90%
CRMDCorMedix Inc3.63-79.46%
CVACCureVac N.V.4.45-74.83%
GLPGGalapagos NV4.86-72.49%
SRPTSarepta Therapeutics Inc4.88-72.36%
ABEOAbeona Therapeutics Inc5.39-69.50%
ABUSArbutus Biopharma Corp5.60-68.32%
ZVRAZevra Therapeutics Inc5.89-66.67%
SPROSpero Therapeutics Inc6.23-64.73%
CGENCompugen Ltd6.31-64.25%
RIGLRigel Pharmaceuticals6.87-61.09%
SLXNSilexion Therapeutics Corp7.30-58.69%
OMEROmeros Corporation9.26-47.58%
AUPHAurinia Pharmaceuticals Inc9.58-45.73%
PLXProtalix BioTherapeutics Inc10.89-38.33%
ACADAcadia Pharmaceuticals Inc11.73-33.59%
TBPHTheravance Biopharma Inc12.26-30.57%
ADMAAdma Biologics Inc12.42-29.69%
HRMYHarmony Biosciences Holdings Inc13.82-21.75%
SABSSAB Biotherapeutics Inc14.14-19.96%
NAGENiagen Bioscience Inc14.82-16.10%
INCYIncyte Corp15.82-10.41%
REGNRegeneron Pharmaceuticals Inc15.86-10.22%
CPRXCatalyst Pharmaceuticals Inc17.44-1.26%
EXELExelixis Inc17.54-0.70%
TGTXTG Therapeutics Inc18.97+7.39%
MDXGMimedx Group Inc20.55+16.37%
XOMAXOMA Royalty Corp22.87+29.52%
ARGXArgen X SE24.30+37.58%
CTMXCytomX Therapeutics Inc24.82+40.54%
XOMAOXOMA Royalty Corp25.34+43.51%
HALOHalozyme Therapeutics Inc25.62+45.09%
XOMAPXOMA Royalty Corp25.67+45.35%
VRTXVertex Pharmaceuticals Inc27.99+58.51%
RPRXRoyalty Pharma plc - Class A28.69+62.44%
SLNOSoleno Therapeutics Inc29.02+64.29%
ASNDAscendis Pharma A/S30.09+70.35%
LGNDLigand Pharmaceuticals Inc - Class B37.91+114.67%
APLSApellis Pharmaceuticals Inc39.02+120.95%
BMRNBiomarin Pharmaceutical Inc42.21+139.01%
KRYSKrystal Biotech Inc45.34+156.75%
ONCBeiGene Ltd69.54+293.75%
PHARPharming Group N.V.75.03+324.81%
TECHBio-Techne Corp101.96+477.31%
VCELVericel Corp109.92+522.40%
ALNYAlnylam Pharmaceuticals Inc117.96+567.95%
GMABGenmab140.29+694.36%
TLXTelix Pharmaceuticals Ltd162.15+818.15%
CORTCorcept Therapeutics Inc212.86+1105.25%